Joseph J. Krivulka serves as Executive at NEKTAR THERAPEUTICS, where they oversee executive responsibilities. Since joining the company, Joseph J. Krivulka has executed 10 insider transactions totaling $100.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 19, 2017 involved receiving (via award) 9,000 shares valued at $0.
Joseph J. Krivulka currently holds 82,000 shares of NEKTAR THERAPEUTICS (NKTR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph J. Krivulka has been a net buyer of NKTR stock. They have purchased $100.0K and sold $0 worth of shares.
Joseph J. Krivulka's most recent insider trade was on Sep 19, 2017, when they sold 9,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $8.37 |
| Discretionary |
| Sep 21, 2016 | NKTR | $0 | Award | 8,000 | $N/A | Discretionary |
| Sep 15, 2016 | NKTR | $0 | Option Exercise | 15,000 | $N/A | Discretionary |
| Jul 24, 2015 | NKTR | $132.2K | Option Exercise | 15,000 | $8.81 | Discretionary |
| Feb 19, 2013 | AOLS | $0 | Purchase | 400,000 | $N/A | Discretionary |
| Apr 5, 2012 | AOLS | $100.0K | Purchase | 333,333 | $0.30 | Discretionary |
| Mar 7, 2011 | NKTR | $0 | Option Exercise | 10,000 | $N/A | Discretionary |
| Nov 14, 2008 | NKTR | $0 | Option Exercise | 5,000 | $N/A | Discretionary |
| Nov 16, 2007 | NKTR | $0 | Award | 5,000 | $N/A | Discretionary |